HPV and HPV-associated diseases

EF Dunne, IU Park - Infectious Disease Clinics, 2013 - id.theclinics.com
Background Papillomaviruses are a family of DNA viruses that infect the epithelium and
have a double-stranded, closed, circular genome of approximately 8 kb and a …

[PDF][PDF] Current trends in the management and prevention of human papillomavirus (HPV) infection

I Ntanasis-Stathopoulos, A Kyriazoglou, M Liontos… - J buon, 2020 - jbuon.com
Purpose: Herein, we critically evaluate and discuss current literature in the field of human
papillomavirus (HPV) pathogenesis, treatment, and prevention. Methods: Screening of the …

The cost-effectiveness of male HPV vaccination in the United States

HW Chesson, DU Ekwueme, M Saraiya, EF Dunne… - Vaccine, 2011 - Elsevier
INTRODUCTION: The objective of this study was to estimate the cost-effectiveness of adding
human papillomavirus (HPV) vaccination of 12-year-old males to a female-only vaccination …

Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis

JJ Kim - The Lancet infectious diseases, 2010 - thelancet.com
Background A vaccine targeting human papillomavirus (HPV) types 16 and 18, which are
associated with 80% of anal cancers, is efficacious in men. High-risk populations such as …

The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK

SC Woodhall, M Jit, K Soldan, G Kinghorn… - Sexually transmitted …, 2011 - sti.bmj.com
Objectives To estimate the loss of quality of life and cost of treatment associated with genital
warts seen in sexual health clinics. Methods A cross-sectional questionnaire study and case …

The impact of anogenital warts on health-related quality of life: a 6-month prospective study

M Drolet, M Brisson, E Maunsell… - Sexually transmitted …, 2011 - journals.lww.com
Background: The burden of anogenital warts will be a determining factor when making
decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or …

Human Papilloma Virus Vaccines

M Stanley - Medicines For Women, 2014 - Springer
Benign and malignant disease caused by HPV (human papillomavirus) constitutes a global
public health problem. Genital warts are the commonest viral sexually transmitted infection …

[HTML][HTML] Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation.

E Thurgar, S Barton, C Karner… - Health Technology …, 2016 - ncbi.nlm.nih.gov
BACKGROUND Typically occurring on the external genitalia, anogenital warts (AGWs) are
benign epithelial skin lesions caused by human papillomavirus infection. AGWs are usually …

Genital warts incidence and healthcare resource utilisation in Australia

M Pirotta, AN Stein, EL Conway, C Harrison… - Sexually transmitted …, 2010 - sti.bmj.com
Objectives To estimate for the first time the incidence and healthcare resource utilisation
associated with genital warts (GW) in Australia prior to the human papillomavirus …

Imiquimod 3.75% cream applied daily to treat anogenital warts: combined results from women in two randomized, placebo‐controlled studies

DA Baker, DG Ferris, MG Martens… - … in obstetrics and …, 2011 - Wiley Online Library
Objective. To evaluate if new imiquimod formulations using a shorter treatment duration are
safe and efficacious to treat anogenital warts. Methods. In two studies 534 women≥ 12 …